v3.26.1
Revenue (Tables)
 3 Months Ended
Mar. 31, 2026
Revenue Recognition [Abstract]  
Schedule of Disaggregation of Revenue
The following table presents the Company’s disaggregated revenue by offering type (in thousands):
 Three Months Ended
March 31,
 20262025
 
Total Net
Revenues
Percentage of
Total Net
Revenues
Total Net
Revenues
Percentage of
Total Net
Revenues
Patient Services revenue recognized at a point in time:
Direct products$673 2.0 %$638 1.8 %
Third-Party Payer products4,868 14.5 %3,951 11.4 %
Patient Services revenue recognized over time:
Direct rental services1,963 5.8 %1,914 5.5 %
Third-Party Payer rental services12,484 37.1 %12,215 35.2 %
Total Patient Services accounted for under ASC 60619,988 59.3 %18,718 53.9 %
Device Solutions revenue recognized at a point in time:
Products3,335 9.9 %4,002 11.5 %
Services
2,792 8.3 %2,350 6.8 %
Device Solutions revenue recognized over time:
Services
149 0.4 %1,855 5.3 %
Total Device Solutions accounted for under ASC 6066,276 18.6 %8,207 23.6 %
Total Revenue Accounted for under ASC 60626,264 78.0 %26,925 77.6 %
Patient Services lease revenue
2,117 6.3 %2,056 5.9 %
Device Solutions lease revenue
5,303 15.7 %5,735 16.5 %
Total Revenue accounted for under ASC 842, Leases7,420 22.0 %7,791 22.4 %
Total Net Revenue$33,684 100.0 %$34,716100.0 %
Schedule of Accounts, Notes, Loans and Financing Receivable
(dollars in thousands)
As of March 31, 2026
As of December 31, 2025
$ Change
Accounts receivable, net$23,980 $22,901 $1,079 
Contract assets$1,222 $1,244 $(22)
Contract liabilities$156 $109 $47